According to a retrospective investigation of two independent cohorts of patients with NSCLC, Helicobacter pylori has been associated with an evident decrease in the PFS of patients with NSCLC undergoing anti-PD-1 therapy (46) (Figure 2). Here, PDCD1 is linked to non-small cell lung carcinoma.